Brainscanology

An objective diagnosis & risk score for common brain diseases delivered in 24hr.

Print
Claim My Business
Security Type
CAFES
Categories
Technology, Social Impact, Financial Services, Healthcare & Medical, Community & Lifestyle
Min Investment
$100
Location
Dublin, CA
Offering Date
December 07, 2020
Expected Close Date
April 30, 2023
Target Raise
$50.00K-$1.07M
No. Investors
65
Security Price
$1
Deal Notes

Discount: 30%

A SAFE gives you the right to future shares in the company. If you invest, you're betting the company will be worth more than $20M in the future.

Number of Employees
2
Cash
$372,595
Revenue
$0
Short Term Debt
$59,037
Cost of Goods
$0
Long Term Debt
$842,741
Net Income
$-508,409

Company Description

We analyze your MRI brain scan to track your risk of developing bipolar disorder, ADHD, dementia, or Alzheimer's Disease. In 5 years, we hope to have raised $5-10 million of Series A funding. These projections are not guaranteed.Given the Company’s limited operating history, the Company cannot reliably estimate how much revenue it will receive in the future, if any.

Perks

Invest $250+ for (1) 1 free risk analysis for a neurological disease of your choice, based on the diseases that we cover. (2) One  BrainScanology t-shirt.
$500+ (1) 3 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (2) One BrainScanology zip-up jacket.
$1,000+ (1) Access to one "invitation only" presentation on BrainScanology's research updates. (2) 8 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (3) One BrainScanology t-shirt + one BrainScanology zip-up jacket.
$10,000+ (1) Wine & Chocolate Gift Basket. (2) Access to one "invitation only" presentation on BrainScanology's research updates. (3) 20 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (4) One BrainScanology t-shirt + one BrainScanology zip-up jacket. (5) Limited edition BrainScanology COVID-19 plastic face shield.
Invest $250+ for (1) 1 free risk analysis for a neurological disease of your choice, based on the diseases that we cover. (2) One  BrainScanology t-shirt.
$500+ (1) 3 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (2) One BrainScanology zip-up jacket.
$1,000+ (1) Access to one "invitation only" presentation on BrainScanology's research updates. (2) 8 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (3) One BrainScanology t-shirt + one BrainScanology zip-up jacket.
$10,000+ (1) Wine & Chocolate Gift Basket. (2) Access to one "invitation only" presentation on BrainScanology's research updates. (3) 20 free risk analyses for a neurological disease of your choice, based on the diseases that we cover. (4) One BrainScanology t-shirt + one BrainScanology zip-up jacket. (5) Limited edition BrainScanology COVID-19 plastic face shield.

Key Deal Facts

We believe our service will be in high demand for providers. Detecting disease early saves $$$.
Our algorithms work for multiple common brain disorders, not just one.
Our co-founder invented the method to measure shapes without area or volume. Not possible 'til now.
Our algorithm is a game-changer that will revolutionize how brain MRIs are analyzed.
Our team is world-class. Check us out.

Use of Proceeds

$50,000

  • 92.5% towards salary to hire full-time employees
  • 7.5% for Wefunder fee

$107,000

  • 15% for marketing
  • 50% towards salary for 1 full-time employee
  • 20% legal & patent fees
  • 7.5% for operation & facilities
  • 7.5% for Wefunder fee

Management Team / Advisory Board Bios

Dave Nguyen
Co-Founder & CEO
Computational biologist who invented the LCPC Transform that measures shapes -- even weird ones -- without using area or volume. BA & PhD from UC Berkeley. Lab: www.TSG-Lab.org

Harini Kumar
Co-Founder
MBA student at UC Davis. Cognitive Science major at UC Santa Cruz. Data scientist.

William Jagust
Advisor
World-renowned expert on Alzheimer's and dementia. A UC Berkeley neuroscience professor.

Michael Cole
Advisor
Clinical psychologist and Berkeley psychology professor. Neuro-health venture capital expert.

Deal Notes

Discount: 30%

A SAFE gives you the right to future shares in the company. If you invest, you're betting the company will be worth more than $20M in the future.

Amount Raised : $88,400
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments